Found 21 matching trials
Contrast-enhanced Ultrasound for Sentinel Node Detection
PHASE2This is a prospective single-center interventional non-inferiority study wh...
Location
Netherlands Cancer Institute
Added Value in Combined Use of Fusion Imaging and Contrast-enhanced Ultrasonography
NASo far, there have been studies showing that the CEUS-grafted technique has...
Location
Seoul National University Hospital
Role of CEUS as a Secondary Diagnostic Modality
NATo determine the role of contrast-enhanced ultrasound (CEUS) as a second-li...
Location
Seoul National University Hospital
Sonazoid CEUS for Early HCC Surveillance
NAThis study is a multicenter, prospective study. In this study, enrolled sub...
Location
Tianjin Third Central Hospital
Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor
N/ASonazoid as a new generation of ultrasound contrast agent.This study based ...
Location
Chinese PLA General Hospital
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC
PHASE3The new version of CEUS LI-RADS published at 2018(version 2017). In this st...
Location
Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University
Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI
PHASE3Patients with renal failure or other reason for contraindication for contra...
Location
Multiple Locations
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer
EARLY_PHASE1This pilot trial studies how well an ultrasound with a contrast agent (perf...
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
PHASE4Liver tumours, 40% of which are benign, account for 1% to 4% of all solid t...
Location
Munich University Hospital
Y-90 Treatment Response Using Transarterial Radioembolization
PHASE2This prospective clinical study will examine the ability of contrast-enhanc...
Location
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University